We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.23%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43B
AUM Growth
+$121M
(+0.28%)
Cap. Flow
-$3.21B
Cap. Flow
% of AUM
-7.47%
Top 10 Holdings %
Top 10 Hldgs %
18.86%
Holding
2,029
New
505
Increased
717
Reduced
446
Closed
331
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$285M |
| 2 |
Applied Materials
AMAT
|
+$234M |
| 3 |
Micron Technology
MU
|
+$185M |
| 4 |
Merck
MRK
|
+$161M |
| 5 |
NXP Semiconductors
NXPI
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$505M |
| 2 |
Bank of America
BAC
|
+$339M |
| 3 |
Nike
NKE
|
+$335M |
| 4 |
Union Pacific
UNP
|
+$329M |
| 5 |
Citigroup
C
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.49% |
| 2 | Financials | 16.82% |
| 3 | Consumer Discretionary | 16.55% |
| 4 | Healthcare | 14.39% |
| 5 | Industrials | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Radian Group
RDN
$4.93B
| $10.4M | 0.02% |
413,436
+57,498
| +16% | +$1.43M |
|
|
FSP
602
Franklin Street Properties
FSP
$46.8M
| $10.3M | 0.02% |
1,201,214
+242,351
| +25% | +$2.08M |
|
603
Universal Insurance Holdings
UVE
$1.23B
| $10.3M | 0.02% |
366,836
+53,297
| +17% | +$1.54M |
|
|
MAG
604
DELISTED
MAG Silver
MAG
| $10.2M | 0.02% |
864,646
+852,046
| +6,762% | +$8.79M |
|
|
VRN
605
DELISTED
Veren
VRN
| $10.2M | 0.02% |
+2,276,354
| New | +$8.9M |
|
606
Sonic Automotive
SAH
$2.61B
| $10.1M | 0.02% |
+327,340
| New | +$10.4M |
|
607
HNI Corp
HNI
$3.59B
| $10.1M | 0.02% |
270,552
+1,757
| +0.7% | +$67.1K |
|
608
Bank OZK
OZK
$5.61B
| $10.1M | 0.02% |
330,737
+117,304
| +55% | +$3.44M |
|
609
Amphastar Pharmaceuticals
AMPH
$916M
| $10.1M | 0.02% |
520,984
+67,149
| +15% | +$1.29M |
|
610
Buckle
BKE
$2.37B
| $9.92M | 0.02% |
+366,921
| New | +$8.73M |
|
|
PNNT
611
Pennant Park Investment Corp
PNNT
$241M
| $9.91M | 0.02% |
1,518,428
+92,940
| +7% | +$578K |
|
612
Tenet Healthcare
THC
$21.1B
| $9.85M | 0.02% |
+259,000
| New | +$7.76M |
|
613
World Kinect Corp
WKC
$1.86B
| $9.81M | 0.02% |
+225,918
| New | +$9.45M |
|
614
Equinor
EQNR
$92.4B
| $9.8M | 0.02% |
492,372
-516,147
| -51% | -$9.76M |
|
615
Turkcell
TKC
$4.79B
| $9.8M | 0.02% |
1,689,322
+910,927
| +117% | +$5.2M |
|
616
Ingevity
NGVT
$2.68B
| $9.71M | 0.02% |
111,169
+24,273
| +28% | +$2.12M |
|
|
CORR
617
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
| $9.63M | 0.02% |
215,314
+25,354
| +13% | +$1.15M |
|
618
Tower Semiconductor
TSEM
$28.5B
| $9.61M | 0.02% |
401,997
+104,889
| +35% | +$2.36M |
|
|
FBM
619
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
| $9.61M | 0.02% |
496,372
+123,422
| +33% | +$2.37M |
|
|
ANAT
620
DELISTED
American National Group, Inc. Common Stock
ANAT
| $9.59M | 0.02% |
81,519
-13,718
| -14% | -$1.62M |
|
621
Weis Markets
WMK
$1.86B
| $9.57M | 0.02% |
236,410
-19,666
| -8% | -$760K |
|
622
OneMain Financial
OMF
$7.47B
| $9.54M | 0.02% |
226,315
-54,219
| -19% | -$2.19M |
|
623
Ingles Markets
IMKTA
$1.67B
| $9.53M | 0.02% |
200,609
+44,453
| +28% | +$1.89M |
|
|
MGLN
624
DELISTED
Magellan Health Services, Inc.
MGLN
| $9.49M | 0.02% |
121,261
+35,305
| +41% | +$2.48M |
|
|
KRA
625
DELISTED
Kraton Corporation
KRA
| $9.44M | 0.02% |
372,916
+189,122
| +103% | +$4.58M |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Arrowstreet Capital held 2,029 positions worth $43B, up 0.28% from $42.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Arrowstreet Capital withdrew a net $3.21B in Q4 2019, closing 331 positions and reducing 446 holdings. Its most notable exit was Celgene Corp, an estimated $505M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Edwards Lifesciences worth $127M.
- Arrowstreet Capital's largest Q4 2019 buy was Edwards Lifesciences: 1,637,208 shares worth $127M.
- Arrowstreet Capital added most to Intel in Q4 2019, an estimated $285M increase.
- Arrowstreet Capital's biggest Q4 2019 reduction was Union Pacific, cutting an estimated $329M.
- Arrowstreet Capital fully exited Celgene Corp in Q4 2019, selling an estimated $505M.
- Arrowstreet Capital's ten largest holdings make up 19% of its $43B portfolio in Q4 2019.
- Arrowstreet Capital opened 505 new positions and closed 331 in Q4 2019.
- Arrowstreet Capital's portfolio value rose 0.28% quarter-over-quarter to $43B.
Based on Arrowstreet Capital's 13F filing for Q4 2019, filed 13 Feb 2020.